Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...

Speaking to Baylor University, study co-author Dr Benjamin Deneen said that increasing levels of the protein, which ...

Chris Hemsworth's new documentary, "A Road Trip to Remember," takes viewers on a motorbike adventure around Melbourne and Australia's Northern Territory. His costar and father, 71-year-old Craig ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

HSBC cut Novo Nordisk to ‘Hold’ after its EVOKE Alzheimer’s trials showed no slowing of disease progression versus placebo.

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, ...

Shares of Novo Nordisk ( NVO 5.58%) fell on Monday, finishing down 5.6%. The drop comes as the S&P 500 and the Nasdaq ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...

Shares of Biogen rose 3% following news of Novo's Alzheimer's trial failure. Biogen and partner Eisai's Leqembi and rival Eli ...

Novo Nordisk A/S’ wild card bet that its GLP-1 receptor agonist semaglutide could be used to treat Alzheimer’s disease has ...